The nano BPP-V and BP-IV epitope vaccines, especially the nano BP-IV epitope vaccine, quickly induced antibody production and a sustained immune response, promoted humoural and cellular immune responses, reduced viral lung damage and provided effective protection against AIV virus infection. Here, SRPX2 is linked to viral infectious disease.